Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. 1995

D J Davidson, and J R Dorin, and G McLachlan, and V Ranaldi, and D Lamb, and C Doherty, and J Govan, and D J Porteous
MRC Human Genetics Unit, Western General Hospital, Edinburgh, UK.

Lung disease is the major cause of death in cystic fibrosis (CF), but there is no evidence for overt lung involvement at birth. We show here that the same is true for the gene targeted cftrm1HGU mutant mouse. Furthermore, this CF mouse model demonstrates an impaired capacity to clear Staphylococcus aureus and Burkholderia (Pseudomonas) cepacia, two opportunistic lung pathogens closely associated with lung disease in CF subjects. The cftrm1HGU homozygotes display mucus retention and frank lung disease in response to repeated microbial exposure. Thus, lung disease in the cftrm1HGU mouse develops in response to bacterial infection, establishing a model to dissect the pathogenesis of CF pulmonary disease and providing a clinically relevant end point to assess the efficacy of pharmacologic or genetic interventions.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D008817 Mice, Mutant Strains Mice bearing mutant genes which are phenotypically expressed in the animals. Mouse, Mutant Strain,Mutant Mouse Strain,Mutant Strain of Mouse,Mutant Strains of Mice,Mice Mutant Strain,Mice Mutant Strains,Mouse Mutant Strain,Mouse Mutant Strains,Mouse Strain, Mutant,Mouse Strains, Mutant,Mutant Mouse Strains,Mutant Strain Mouse,Mutant Strains Mice,Strain Mouse, Mutant,Strain, Mutant Mouse,Strains Mice, Mutant,Strains, Mutant Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D009894 Opportunistic Infections An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression. Infection, Opportunistic,Infections, Opportunistic,Opportunistic Infection
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D J Davidson, and J R Dorin, and G McLachlan, and V Ranaldi, and D Lamb, and C Doherty, and J Govan, and D J Porteous
January 2011, Methods in molecular biology (Clifton, N.J.),
D J Davidson, and J R Dorin, and G McLachlan, and V Ranaldi, and D Lamb, and C Doherty, and J Govan, and D J Porteous
July 2014, The international journal of biochemistry & cell biology,
D J Davidson, and J R Dorin, and G McLachlan, and V Ranaldi, and D Lamb, and C Doherty, and J Govan, and D J Porteous
February 2016, Medecine et maladies infectieuses,
D J Davidson, and J R Dorin, and G McLachlan, and V Ranaldi, and D Lamb, and C Doherty, and J Govan, and D J Porteous
August 2008, The European respiratory journal,
D J Davidson, and J R Dorin, and G McLachlan, and V Ranaldi, and D Lamb, and C Doherty, and J Govan, and D J Porteous
May 2015, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society,
D J Davidson, and J R Dorin, and G McLachlan, and V Ranaldi, and D Lamb, and C Doherty, and J Govan, and D J Porteous
September 2022, Journal of the Pediatric Infectious Diseases Society,
D J Davidson, and J R Dorin, and G McLachlan, and V Ranaldi, and D Lamb, and C Doherty, and J Govan, and D J Porteous
June 2005, Respiratory research,
D J Davidson, and J R Dorin, and G McLachlan, and V Ranaldi, and D Lamb, and C Doherty, and J Govan, and D J Porteous
April 1983, Lancet (London, England),
D J Davidson, and J R Dorin, and G McLachlan, and V Ranaldi, and D Lamb, and C Doherty, and J Govan, and D J Porteous
February 2017, Pediatric pulmonology,
D J Davidson, and J R Dorin, and G McLachlan, and V Ranaldi, and D Lamb, and C Doherty, and J Govan, and D J Porteous
September 2021, Microbiology spectrum,
Copied contents to your clipboard!